Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2018-12-20 2018-12-20
Drug Identification Number 00755338 00755338
Brand name SOLYSTAT SOLYSTAT
Common or Proper name SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC PENDOPHARM DIVISION OF PHARMASCIENCE INC
Ingredients SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE
Strength(s) 94.3MG 94.3MG
Dosage form(s) POWDER POWDER
Route of administration ORAL RECTAL ORAL RECTAL
Packaging size 454G 454G
ATC code V03AE V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-11-19 2018-11-19
Actual start date 2018-11-15 2018-11-15
Estimated end date 2018-12-27 2018-12-27
Actual end date 2018-12-14 2018-12-14
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Solystat remains available in 500mL and 60mL U.D. formats. Solystat remains available in 500mL and 60mL U.D. formats.
Health Canada comments